Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Invested Capital (2020 - 2025)

iSpecimen has reported Invested Capital over the past 6 years, most recently at $3.1 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 6.73% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $3.1 million, down 6.73%, while the annual FY2025 figure was $3.1 million, 6.73% down from the prior year.
  • Invested Capital for Q4 2025 was $3.1 million at iSpecimen, up from $3.1 million in the prior quarter.
  • Over five years, Invested Capital peaked at $29.8 million in Q4 2021 and troughed at -$31.2 million in Q1 2021.
  • A 5-year average of $10.2 million and a median of $10.9 million in 2021 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: skyrocketed 231.31% in 2021 and later crashed 89.79% in 2025.
  • Year by year, Invested Capital stood at $29.8 million in 2021, then crashed by 31.83% to $20.3 million in 2022, then tumbled by 52.04% to $9.7 million in 2023, then crashed by 66.01% to $3.3 million in 2024, then decreased by 6.73% to $3.1 million in 2025.
  • Business Quant data shows Invested Capital for ISPC at $3.1 million in Q4 2025, $3.1 million in Q3 2025, and $621973.0 in Q2 2025.